A rare presentation of neurofibromatosis 2 as quadriparesis
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232818Keywords:
Neurofibromatosis 2, Quadriplegia, Meningioma, NeurofibromasAbstract
Neurofibromatosis (NF) is a complex genetic disorder primarily recognized for its characteristic tumors affecting the nervous system and skin. We present an exceptional case of a patient diagnosed with NF type 2, exhibiting an atypical clinical manifestation-quadriplegia. This case underscores the rarity of such a presentation, as NF typically presents with neurocutaneous features such as café-au-lait macules, neurofibromas, and meningiomas. Our patient, a 46-year-old male, presented with gradual onset quadriplegia without any preceding symptoms of NF. Radiological evaluation revealed meningiomas as well as extensive spinal neurofibromas compressing the spinal cord. This case exemplifies the importance of considering NF as a differential diagnosis in patients presenting with unexpected neurological deficits. Timely recognition and management of such cases are crucial for preventing irreversible neurological damage. This report adds to the growing body of knowledge regarding the diverse clinical presentations of NF and emphasizes the need for comprehensive assessment and multidisciplinary collaboration in managing this intricate disorder within the realm of medicine.
Metrics
References
Rouleau GA, Merei P, Lutchman M, Sanson M, Zucman J, Marineau C et al. Alteration in a new gene encoding a putative membrane organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363(6429);515.
Evans DG. Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next generation sequencing. Genet Med. 2020;22(1):53.
Forde C. Disease course of neurofibromatosis type 2: a 30 year followup study of 353 patients seen at a single institution. Neuro Oncol. 2021;23(7);1113.
Gaudioso C. Neurofibromatosis 2 in children presenting during the first decade of life. Neurology. 2019;93(10):e964.
Evans DG. A clinical study of type 2 neurofibromatosis. Q J Med. 1992;84(304):603.
Bosch MM. Ophthalmological findings and long term course in patients with neurofibromatosis type 2. Am J Ophthalmol. 2006;141(6):1068.
Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J. Skin abnormalities in neurofibromatosis 2. Arch Dermatol. 1997;133(12):1539.
Sobel RA, Wang Y. Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol. 1993;52:106-13.
Evans DG, Watson C, King A, Wallace AJ, Baser ME. Multiple meningiomas: differential involvement of the NF2 gene in children and adults. J Med Genet. 2005;42:45-8.
Antinheimo J, Haapasalo H, Haltia M. Proliferation potential and histological features in neurofibromatosis 2-associated and sporadic meningiomas. J Neurosurg. 1997;87:610-14.